Marwan Sabbagh - 14 Mar 2022 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
Director
Signature
/s/ Caryn McDowell, Attorney-in-Fact for Marwan Sabbagh
Issuer symbol
QNCX
Transactions as of
14 Mar 2022
Transactions value $
$0
Form type
4
Filing time
16 Mar 2022, 18:33:46
Next filing
24 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Award $0 +22.1K $0.00 22.1K 14 Mar 2022 Common Stock 22.1K $4.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest in equal annual installments over the three-year period following the grant date of March 14, 2022.